Relay Therapeutics, Inc. RLAY Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s operating income?
- Relay Therapeutics, Inc. (RLAY) reported operating income of -$78.59M in Q1 2026.
- How has Relay Therapeutics, Inc.'s operating income changed year-over-year?
- Relay Therapeutics, Inc.'s operating income increased by 7.4% year-over-year, from -$84.87M to -$78.59M.
- What is the long-term trend for Relay Therapeutics, Inc.'s operating income?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s operating income has grown at a -4.5% compound annual growth rate (CAGR), from -$364.7M to -$302.74M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.